Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
531.288577443
InChI
InChI=1S/C35H37N3O2/c1-23-19-24(2)36-34-32(23)29-17-8-9-18-31(29)38(34)21-25-11-10-16-28(20-25)33(27-14-6-7-15-27)35(40)37-30(22-39)26-12-4-3-5-13-26/h3-5,8-13,16-20,27,30,33,39H,6-7,14-15,21-22H2,1-2H3,(H,37,40)/t30-,33-/m0/s1
InChI Key
InChIKey=AMNXBQPRODZJQR-DITALETJSA-N
IUPAC Name
(2S)-2-cyclopentyl-2-[3-({2,4-dimethyl-9H-pyrido[2,3-b]indol-9-yl}methyl)phenyl]-N-[(1R)-2-hydroxy-1-phenylethyl]acetamide
Traditional IUPAC Name
(2S)-2-cyclopentyl-2-[3-({2,4-dimethylpyrido[2,3-b]indol-9-yl}methyl)phenyl]-N-[(1R)-2-hydroxy-1-phenylethyl]acetamide
SMILES
CC1=NC2=C(C3=CC=CC=C3N2CC2=CC(=CC=C2)[C@H](C2CCCC2)C(=O)N[C@@H](CO)C2=CC=CC=C2)C(C)=C1
pKa (strongest acidic)
13.4
pKa (Strongest Basic)
4.35
Refractivity
160.14 m3·mol-1
Dược Lực Học :
Implitapide is an inhibitor of microsomal triglyceride transfer protein (MTP), a key enzyme involved in the assembly and release of cholesterol and triglyceride from the liver and intestinal tract. It is being investigated for the treatment of atherosclerosis.
Cơ Chế Tác Dụng :
Implitapide is a microsomal triglyceride transfer protein (MTP)-inhibitor.
MTP mediates triglyceride absorption and chylomicron secretion from the intestine and very-low-density lipoprotein (VLDL) secretion from the liver by linking lipid molecules with apolipoprotein B (apoB). Inhibition of MTP reduces the level of all apoB-containing lipoproteins, including LDL.
Chỉ Định :
For the treatment of atherosclerosis.